CD8A and myeloid sarcoma: Given the metabolic adaptations downstream of TCR signaling that converge to increase PPP engagement, we sought to determine whether PPP engagement is increased in autoaggressive disease states such as MS and if inhibition of the PPP would disrupt cytotoxic effector functions to ameliorate CD8+ T cell–mediated axonal injury in the demyelinated CNS.